308 related articles for article (PubMed ID: 27974628)
1. Quantitative Microbial Risk Assessment of Pharmaceutical Products.
Eissa ME
PDA J Pharm Sci Technol; 2017; 71(3):245-251. PubMed ID: 27974628
[TBL] [Abstract][Full Text] [Related]
2. Contamination Control.
Akers MJ
Int J Pharm Compd; 2015; 19(3):232-8. PubMed ID: 26714364
[TBL] [Abstract][Full Text] [Related]
3. A QRM Discussion of Microbial Contamination of Non-sterile Drug Products, Using FDA and EMA Warning Letters Recorded between 2008 and 2016.
Santos AMC; Doria MS; Meirinhos-Soares L; Almeida AJ; Menezes JC
PDA J Pharm Sci Technol; 2018; 72(1):62-72. PubMed ID: 29242394
[TBL] [Abstract][Full Text] [Related]
4. Validation of Milliflex
Gordon O; Goverde M; Staerk A; Roesti D
PDA J Pharm Sci Technol; 2017; 71(3):206-224. PubMed ID: 28196917
[TBL] [Abstract][Full Text] [Related]
5. Validation Study of Rapid Assays of Bioburden, Endotoxins and Other Contamination.
Shintani H
Biocontrol Sci; 2016; 21(2):63-72. PubMed ID: 27350424
[TBL] [Abstract][Full Text] [Related]
6. Creating a Holistic Extractables and Leachables (E&L) Program for Biotechnology Products.
Li K; Rogers G; Nashed-Samuel Y; Lee H; Mire-Sluis A; Cherney B; Forster R; Yeh P; Markovic I
PDA J Pharm Sci Technol; 2015; 69(5):590-619. PubMed ID: 26429108
[TBL] [Abstract][Full Text] [Related]
7. Equipment and analytical companies meeting continuous challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
Page T; Dubina H; Fillipi G; Guidat R; Patnaik S; Poechlauer P; Shering P; Guinn M; Mcdonnell P; Johnston C
J Pharm Sci; 2015 Mar; 104(3):821-31. PubMed ID: 25448273
[TBL] [Abstract][Full Text] [Related]
8. Revision of Viable Environmental Monitoring in a Development Pilot Plant Based on Quality Risk Assessment: A Case Study.
Ziegler I; Borbély-Jakab J; Sugó L; Kovács RJ
PDA J Pharm Sci Technol; 2017; 71(3):234-244. PubMed ID: 28089966
[TBL] [Abstract][Full Text] [Related]
9. Managing the microbiological quality of pharmaceutical excipients.
Cundell AM
PDA J Pharm Sci Technol; 2005; 59(6):381-95. PubMed ID: 16471425
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Different Calculation Approaches for Defining Microbiological Control Levels Based on Historical Data.
Gordon O; Goverde M; Pazdan J; Staerk A; Roesti D
PDA J Pharm Sci Technol; 2015; 69(3):383-98. PubMed ID: 26048745
[TBL] [Abstract][Full Text] [Related]
11. A practical discussion of risk management for manufacturing of pharmaceutical products.
Mollah AH; Baseman HS; Long M; Rathore AS
PDA J Pharm Sci Technol; 2014; 68(3):271-80. PubMed ID: 25188348
[TBL] [Abstract][Full Text] [Related]
12. Gamma sterilization of pharmaceuticals--a review of the irradiation of excipients, active pharmaceutical ingredients, and final drug product formulations.
Hasanain F; Guenther K; Mullett WM; Craven E
PDA J Pharm Sci Technol; 2014; 68(2):113-37. PubMed ID: 24668600
[TBL] [Abstract][Full Text] [Related]
13. Risk reduction in biotherapeutic products.
Ill CR; Dehghani H
Curr Opin Drug Discov Devel; 2009 Mar; 12(2):296-304. PubMed ID: 19333875
[TBL] [Abstract][Full Text] [Related]
14. Risk analysis of sterile production plants: a new and simple, workable approach.
Gapp G; Holzknecht P
PDA J Pharm Sci Technol; 2011; 65(3):217-26. PubMed ID: 22293233
[TBL] [Abstract][Full Text] [Related]
15. Toward Higher QA: From Parametric Release of Sterile Parenteral Products to PAT for Other Pharmaceutical Dosage Forms.
Hock SC; Constance NX; Wah CL
PDA J Pharm Sci Technol; 2012; 66(4):371-91. PubMed ID: 22767885
[TBL] [Abstract][Full Text] [Related]
16. Industrial approaches and consideration of clinical relevance in setting impurity level specification for drug substances and drug products.
Pokar D; Rajput N; Sengupta P
Int J Pharm; 2020 Feb; 576():119018. PubMed ID: 31911117
[TBL] [Abstract][Full Text] [Related]
17. Microbial diversity in pharmaceutical product recalls and environments.
Jimenez L
PDA J Pharm Sci Technol; 2007; 61(5):383-99. PubMed ID: 18047177
[TBL] [Abstract][Full Text] [Related]
18. In-process microbial testing: statistical properties of a rapid alternative to compendial enumeration methods.
Friedman EM; Warner M; Shum SC; Adair F
PDA J Pharm Sci Technol; 2015; 69(2):264-9. PubMed ID: 25868992
[TBL] [Abstract][Full Text] [Related]
19. Microbiological quality control of some non-sterile preparations commonly used in Pakistan.
Rauf A; Erum A; Noreen S; Shujaat J; Ashraf MU; Afreen S
Pak J Pharm Sci; 2018 Jul; 31(4):1237-1242. PubMed ID: 30033406
[TBL] [Abstract][Full Text] [Related]
20. A PAT-based qualification of pharmaceutical excipients produced by batch or continuous processing.
Hertrampf A; Müller H; Menezes JC; Herdling T
J Pharm Biomed Anal; 2015 Oct; 114():208-15. PubMed ID: 26072012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
